Literature DB >> 7045511

Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects.

M G Bianchetti, I Minder, C Beretta-Piccoli, A Meier, P Weidmann.   

Abstract

Responses of blood pressure and plasma catecholamines to intravenous injection of tyramine at increasing dosage (30, 45, and 60 microgram/kg, respectively) were evaluated in 25 normal subjects and 20 patients with mild essential hypertension. Basal plasma norepinephrine and epinephrine concentrations before tyramine injections were similar in the two groups. Following tyramine injection, plasma epinephrine was unchanged. Responses of plasma catecholamines and blood pressure to tyramine were similar in the two groups. Plasma norepinephrine increased significantly 2 min after a dose of 30 microgram/kg, but higher tyramine doses failed to produce a further increase in plasma norepinephrine. In contrast, pressor responses to tyramine were dose-dependent. Maximal pressor responses were observed within 23 min after injection. These findings reveal a dissociation between changes in blood pressure and plasma norepinephrine following injection of tyramine. Lack of steady state may limit the value of tyramine bolus injections as a tool for the quantitation of pressor responsiveness to variations in endogenous sympathetic output. Alternatively, it is possible that the pressor effect of tyramine may be mediated at least in part by a norepinephrine independent mechanism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7045511     DOI: 10.1007/bf01720361

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  33 in total

1.  The mode of action of tyramine.

Authors:  M J DAVEY; J B FARMER
Journal:  J Pharm Pharmacol       Date:  1963-03       Impact factor: 3.765

2.  The action of sympathomimetic amines in animals treated with reserpine.

Authors:  J H BURN; M J RAND
Journal:  J Physiol       Date:  1958-12-04       Impact factor: 5.182

3.  Pressor effects of norepinephrine after drastic reduction of sodium intake.

Authors:  L K DAHL
Journal:  Circulation       Date:  1957-02       Impact factor: 29.690

4.  The hemodynamic response of man to nor-epinephrine and epinephrine and its relation to the problem of hypertension.

Authors:  M GOLDENBERG; K L PINES
Journal:  Am J Med       Date:  1948-12       Impact factor: 4.965

5.  Analysis of the effect of tyramine and norepinephrine in isolated canine cerebral and mesenteric arteries.

Authors:  N Toda; S Hayashi; K Hattori
Journal:  J Pharmacol Exp Ther       Date:  1978-05       Impact factor: 4.030

6.  Effect of sodium intake on plasma catecholamines in normal subjects.

Authors:  M S Romoff; G Keusch; V M Campese; M S Wang; R M Friedler; P Weidmann; S G Massry
Journal:  J Clin Endocrinol Metab       Date:  1979-01       Impact factor: 5.958

7.  Intact hindquarter vascular responses of young spontaneously hypertensive rats to norepinephrine and tyramine.

Authors:  J Y Lee; G M Walsh; A J Tobia
Journal:  Life Sci       Date:  1980-06-02       Impact factor: 5.037

8.  Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension.

Authors:  P Weidmann; C Beretta-Piccoli; W H Ziegler; G Keusch; Z Glück; F C Reubi
Journal:  Kidney Int       Date:  1978-12       Impact factor: 10.612

9.  Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.

Authors:  D Robertson; G A Johnson; R M Robertson; A S Nies; D G Shand; J A Oates
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

10.  Plasma-noradrenaline in essential hypertension.

Authors:  P S Sever; B Osikowska; M Birch; R D Tunbridge
Journal:  Lancet       Date:  1977-05-21       Impact factor: 79.321

View more
  11 in total

1.  Dopamine contamination of infused tyramine.

Authors:  Courtney Holmes; Jeffrey Moak; Basil Eldadah; Ella Zimmerly; Yehonatan Sharabi; David S Goldstein
Journal:  Clin Chem       Date:  2005-07-21       Impact factor: 8.327

Review 2.  Genotype and vascular phenotype linked by catecholamine systems.

Authors:  David S Goldstein
Journal:  Circulation       Date:  2008-01-29       Impact factor: 29.690

3.  Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine.

Authors:  Brianna B Williams; Andrew H Van Benschoten; Peter Cimermancic; Mohamed S Donia; Michael Zimmermann; Mao Taketani; Atsushi Ishihara; Purna C Kashyap; James S Fraser; Michael A Fischbach
Journal:  Cell Host Microbe       Date:  2014-09-25       Impact factor: 21.023

4.  Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension.

Authors:  Yehonatan Sharabi; Richard Imrich; Courtney Holmes; Sandra Pechnik; David S Goldstein
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

5.  The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors.

Authors:  Vincent Van den Eynde
Journal:  J Neural Transm (Vienna)       Date:  2021-08-09       Impact factor: 3.575

Review 6.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

7.  Dietary trace amine-dependent vasoconstriction in porcine coronary artery.

Authors:  A A Herbert; E J Kidd; K J Broadley
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

8.  Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension.

Authors:  Richard Imrich; Basil A Eldadah; Oladi Bentho; Sandra Pechnik; Yehonatan Sharabi; Courtney Holmes; Ehud Grossman; David S Goldstein
Journal:  Parkinsonism Relat Disord       Date:  2008-05-29       Impact factor: 4.891

Review 9.  Neurogenic orthostatic hypotension: a pathophysiological approach.

Authors:  David S Goldstein; Yehonatan Sharabi
Journal:  Circulation       Date:  2009-01-06       Impact factor: 29.690

10.  The effect of angiotensin II on haemodynamic and plasma noradrenaline responses to tyramine infusion in man.

Authors:  P H Seidelin; A D Struthers
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.